VitaNova Life Sciences Corporation SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount
VitaNova Life Sciences Corporation (VNOV) had SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount of $39.33 thousand as of 2020-04-30, per its 10-K filed 2020-08-05.
Discontinued › Notes
us-gaap:ValuationAllowancesAndReservesBalance · last filed 2020-08-05
- 2020-04-30: SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount $39.33K.
- 2019-04-30: SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount $24.14K.
| Period end | SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount |
|---|---|
| 2020-04-30 | $39.33K 10-K · filed 2020-08-05 |
| 2019-04-30 | $24.14K 10-K · filed 2020-08-05 |